Pages
Changes to MyDCHS
Changes to MyDCHS
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/changes-mydchs
Friday 23 December – latest update on critical incident status
https://dchs.nhs.uk/news/friday-23-december-latest-update-critical-incident-status
Building Belper’s new health centre.. A peek at progress on site!
https://dchs.nhs.uk/news/building-belpers-new-health-centre-peek-progress-site
Access to journal articles for DCHS staff
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/access-journal-articles-dchs-staff
Derbyshire NHS Trust’s annual public accountability meeting
https://dchs.nhs.uk/news/derbyshire-nhs-trusts-annual-public-accountability-meeting-1
Carers’ Rights Day – Thursday 20 November
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/carers-rights-day-thursday-20-november
Baby loss Awareness Week 9 – 15 October
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/baby-loss-awareness-week-9-15-october
Files
Clinical Harms Review Additional detail for Service Level SOP - Community Podiatry Service (S113)
This document should be read in conjunction with the overarching DCHS Standard Operating procedure on Clinical Harms which outlines the processes to be followed in order to deliver a consistent approach to: • Utilising a proactive method of risk stratification to minimise clinical harm as a result of delays in care. • Embedding systems which consider health inequalities. • Monitoring waiting times against defined thresholds across pathways of care. • Delivering personalised, patient-centred communications to patients who are waiting for care. • Implementing Harm Reviews for the that support the Trusts governance and assurance processes and maintains practice in line with national expectations.
A2 - Derbyshire Children’s Continence Service L2 referral pathway for product provision (P91)
A2 - Derbyshire Children’s Continence Service L2 referral pathway for product provision
Mental Health Act 1983 - Detention of Informal Patients under Section 5(4) Policy and Procedure (P104)
This policy provides guidance on the use of Section 5(4), nurses holding power under the Mental Health Act 1983. It should be followed by all Registered Mental Health Nurses and Learning Disability Nurses working in trust in-patient areas. This short-term power, not more than six hours, can be applied to informal patients under certain conditions as below. This policy should be read in conjunction with Chapter 18 ‘Holding powers’ of the Mental Health Act 1983 Code of Practice (2015).
Disclosure Ref 2024134 - List of Medications To Be Used in Nursing Teams.pdf
FOI Disclosure Ref 2024134 - List of Medications To Be Used in Nursing Teams
Core Standards Template (DCHS Policy Development Framework)
Core Standards Template (DCHS Policy Development Framework)
Disclosure Ref 2024144 - Private maternity services .pdf
Private maternity services
Clinical Harms Review Additional detail for Service Level SOP - Dementia Palliative Care (S133)
This document should be read in conjunction with the overarching DCHS Standard Operating procedure on Clinical Harms which outlines the processes to be followed to deliver a consistent approach to. • Risk stratification to minimise clinical harm as a result of delays in care. • Embedding systems which take into account health inequalities. • Monitoring waiting times against defined thresholds across pathways of care. • Delivering personalised, patient-centred communications to patients who are waiting for care. • Implementing Harm Reviews that support the Trusts governance and assurance processes and maintains practice in line with national expectations. The intention of the service level document is to provide specific detail on. • The risk stratification process in operation and clinically appropriate to specific service lines and patient cohorts • Waiting time thresholds for the relevant patient pathways
Pressure Ulcer Categories
Pressure Ulcer Categories
Disclosure Ref 202510 - Ransonware attacks 2019 to 2024.pdf
Disclosure to freedom of information request regarding the number of ransomware attacks on your organisation between 2019 and 2024
Disclosure Ref 202534 - Spend on Sodium Hyaluronate eye drop.pdf
Freedom of information disclosure regarding spend on Sodium Hyaluronate eye drop